- Home
- SMID vs SCPH Comparison
SMID vs SCPH Comparison
Compare SMID & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMID
- SCPH
- Stock Information
- Founded
- SMID 1960
- SCPH 2013
- Country
- SMID United States
- SCPH United States
- Employees
- SMID N/A
- SCPH N/A
- Industry
- SMID Building Materials
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- SMID Industrials
- SCPH Health Care
- Exchange
- SMID Nasdaq
- SCPH Nasdaq
- Market Cap
- SMID 163.4M
- SCPH 163.3M
- IPO Year
- SMID 1995
- SCPH 2017
- Fundamental
- Price
- SMID $32.65
- SCPH $5.31
- Analyst Decision
- SMID
- SCPH Strong Buy
- Analyst Count
- SMID 0
- SCPH 2
- Target Price
- SMID N/A
- SCPH $19.00
- AVG Volume (30 Days)
- SMID 35.1K
- SCPH 258.3K
- Earning Date
- SMID 11-07-2024
- SCPH 11-06-2024
- Dividend Yield
- SMID N/A
- SCPH N/A
- EPS Growth
- SMID N/A
- SCPH N/A
- EPS
- SMID 0.87
- SCPH N/A
- Revenue
- SMID $68,434,000.00
- SCPH $24,048,000.00
- Revenue This Year
- SMID N/A
- SCPH $195.62
- Revenue Next Year
- SMID N/A
- SCPH $145.07
- P/E Ratio
- SMID $36.31
- SCPH N/A
- Revenue Growth
- SMID 26.77
- SCPH 549.77
- 52 Week Low
- SMID $17.36
- SCPH $3.24
- 52 Week High
- SMID $48.87
- SCPH $7.55
- Technical
- Relative Strength Index (RSI)
- SMID 52.35
- SCPH 58.35
- Support Level
- SMID $29.71
- SCPH $4.97
- Resistance Level
- SMID $32.00
- SCPH $5.30
- Average True Range (ATR)
- SMID 2.43
- SCPH 0.26
- MACD
- SMID -0.22
- SCPH -0.01
- Stochastic Oscillator
- SMID 49.75
- SCPH 76.27
About SMID Smith-Midland Corporation
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.